Apoptotic Cells for Therapeutic Use in Cytokine Storm Associated With Sepsis– A Phase Ib Clinical Trial

BACKGROUND: Sepsis has no proven specific pharmacologic treatment and reported mortality ranges from 30%–45%. The primary aim of this phase IB study was to determine the safety profile of Allocetra™-OTS (early apoptotic cell) infusion in subjects presenting to the emergency room with sepsis. The sec...

Descripción completa

Detalles Bibliográficos
Autores principales: van Heerden, Peter Vernon, Abutbul, Avraham, Sviri, Sigal, Zlotnick, Eitan, Nama, Ahmad, Zimro, Sebastian, el-Amore, Raja, Shabat, Yehudit, Reicher, Barak, Falah, Batla, Mevorach, Dror
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515139/
https://www.ncbi.nlm.nih.gov/pubmed/34659208
http://dx.doi.org/10.3389/fimmu.2021.718191

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515139/
https://www.ncbi.nlm.nih.gov/pubmed/34659208
http://dx.doi.org/10.3389/fimmu.2021.718191

Ejemplares similares